Liu Ye

Liu Ye graduated from Beijing Medical University(now change name as Peking University Health Science Center) with a major in medicinal chemistry, Later obtained a doctorate degree in medicinal chemistry at Uppsala University, Sweden. He has worked in international pharmaceutical companies such as KaroBio AB, Pharmacia & Upjohn, and he also has rich experience in cooperation with well-known pharmaceutical companies such as Merck, Abbott, and Wyeth in drug discovery. In 2002, he returned to China to establish Beijing Honghui meditech Co.,Ltd. and served as the company's CEO, He was also the chief scientist of the Daxing Bio-medicine Industry Park in Daxing District, Beijing. He has presided over the establishment of more than 500 scientific research projects, including 4 first-class new drugs development, and obtained a number of patents on drug research and development.

Tong Weimin

Tong Weimin graduated from the Department of Chemistry,Peking University,Received a PhD in Bioorganic Chemistry from Uppsala University, Sweden in 1993,Later, he studied as a postdoctoral fellow in the Department of Pharmaceutical Organic Chemistry,Uppsala University, Worked in ChemiliaAB, TripepAB, Pharmacia & Upjohn and other international pharmaceutical companies, especially good at new drug research in the field of nucleosides, He has published many high-level papers and holds 3 patents.

 Cai Yang

Cai Yang graduated from Beijing Medical University(now change name as Peking University Health Science Center) with a major in medicinal chemistry,Obtained a master's degree in pharmacognosy from the Faculty of Pharmacy, Osaka University, Japan in 1986.In 1989, he received a PhD in Pharmacognosy from the Faculty of Pharmacy, Osaka University, Japan, and then studied as a postdoctoral fellow at the Biological Center of Ciba-Geigy, Switzerland.

Zhang Xiao

Obtained a master's degree in pharmacology and toxicology from the Academy of Military Medical Sciences,Ph.D. in General Medicine, Hiroshima University School of Medicine, Japan,He also studied as a postdoctoral fellow in the Department of Pharmacology, School of Pharmacy, Uppsala University, Sweden, and has a solid technical foundation in neurophysiology and pharmacology.

Mu Hongtao

Graduated from the Institute of Elemental Organic Chemistry, Nankai University in 2007, joined the company after graduation,So far, he has been engaged in and responsible for the difficult organic synthesis research work in drug-related fields.

Lv Jiuan

Lv Jiuan graduated from Shenyang Pharmaceutical University with a major in pharmaceutical engineering and obtained a master's degree in medicinal chemistry from Shenyang Pharmaceutical University in 2008. After graduation, he joined the company and has been engaged in and responsible for the research and development of chemical generic drugs.

Zhang Pingping

Zhang Pingping graduated from Shandong University of Technology with a major in chemical engineering and technology, and later obtained a master's degree in applied chemistry from Beijing University of Chemical Technology. After graduation, he joined the company and has been mainly involved in and responsible for the synthesis and screening of new drugs entrusted by foreign customers such as Johnson & Johnson, Phnomix, Medivir, Idennix, etc. Currently, he is engaged in the research and development of innovative drugs of cardiovascular and cerebrovascular classes with independent intellectual property rights in the company.